Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer

NCT03768349 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03768349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03768349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
January 3, 2019
Completion date
July 21, 2021
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer